Warnex Inc.

Warnex Inc.

August 11, 2006 07:00 ET

Warnex and Eppendorf form strategic alliance

LAVAL, QC, AUG. 11 - Warnex Inc. (TSX:WNX) today announced that it
has formed a strategic alliance with Eppendorf, a global leader in the
laboratory equipment market, which will combine Eppendorf's state-of-the-art
Mastercycler® ep realplex real-time PCR system with Warnex's pathogen
detection kits and software to provide enhanced food safety tests.

"In addition to offering our customers cutting-edge technology and high
quality detection products, we are committed to providing them with superior
technical support and customer service," said Mark Busgang, President and CEO
of Warnex. "Our alliance with Eppendorf, a leader in the field of laboratory
equipment and world-renowned for its level of quality and service, reflects
our joint commitment to meet the needs of the industry."

"We are pleased to align with Warnex, a leader in the development of
pathogen detection kits, permitting us to enter into the food diagnostics
market," said Klaus Fink, President and CEO of Eppendorf AG. "With their
scientific expertise and strong commitment to research and development, Warnex
has developed a broad portfolio of pathogen detection tests and has led the
way with quantitative real-time PCR tests. Together, our expertise will
generate a complete and state-of-the-art food testing solution providing
significant customer benefits."

The Warnex™ Rapid Pathogen Detection System offers a versatile
detection and quantification platform, using real-time PCR technology combined
with proprietary genetic markers and software, to rapidly and accurately
determine the presence of pathogens in a sample. The system allows for the
simultaneous detection of multiple pathogens and processing of samples within
3 to 48 hours, a significant improvement over traditional microbiology tests
that require 5 to 7 days.

Warnex will offer Eppendorf's Mastercycler ep realplex real-time PCR
system as an additional platform for its proprietary pathogen tests. The
Mastercycler ep realplex (www.mastercycler.com) features the latest
technology, combined with superior design and a quality finish. Powered by a
highly accurate and uniform thermal engine, the system allows for multiplexing
with 2 or 4 emission filters and comes with a full real time-PCR licence.

About Warnex

Warnex (www.warnex.ca) is a biotechnology company devoted to protecting
public health by providing advanced diagnostic products and science-based
services to the agri-food, pharmaceutical and healthcare sectors. Warnex's
DNA-based technology offers a versatile detection platform that produces
accurate results rapidly, using Real-Time PCR technology combined with unique
genetic markers and software. With a focus on pathogen detection in food, our
development pipeline also includes applications in GMO testing and meat
speciation, as well as in the detection of viruses, yeasts and moulds.
Warnex's analytical, bioanalytical, and medical laboratory service groups
offer a variety of quality control services, method development and
validation, contract R&D, bioavailability and bioequivalence studies for
clinical trials, and medical laboratory testing.

About Eppendorf

The Eppendorf Group (www.eppendorf.com), based in Hamburg, Germany, is a
leading supplier of systems and research tools for the life science industry
worldwide. Eppendorf manufactures instruments and consumables for liquid
handling including solutions for automation as well as a range of PCR and
real-time PCR products. Eppendorf is a market leader in microcentrifugation
with a full range of products for many areas of research. Other products
comprise sample preparation, detection and cell technology research. Many of
its products such as certain plastic consumables, pipettes and centrifuges are
considered market-leading standards and have highest brand recognition. In
fiscal 2005, Eppendorf employed approximately 1,800 people worldwide and
expects to achieve sales of 321 million Euros (approx. 365 million US
Dollars), which represents a growth rate of approximately 12% compared to
prior year results.

Warnex is a trademark of Warnex Inc., Laval, Quebec.


Certain statements contained in this news release are forward-looking and
are subject to numerous risks and uncertainties, known and unknown. For
information identifying known risks and uncertainties, relating to the early
commercialization of Warnex products, intellectual property and licensing, R&D
of new Warnex products, integration of acquisitions, manufacturing and
laboratory facilities, suppliers, key employees, key customers and business
partners, financial resources and credit risk, government regulations, foreign
currency risk and volatility of share price, and other important factors that
could cause actual results to differ materially from those anticipated in the
forward-looking statements, please refer to the heading Risks and
Uncertainties in the Management's Discussion and Analysis for the second
quarter ended June 30, 2006, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated
results expressed in these forward-looking statements.

Contact Information